Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 367

1.

Persistent HIV-1 replication during antiretroviral therapy.

Martinez-Picado J, Deeks SG.

Curr Opin HIV AIDS. 2016 Apr 13. [Epub ahead of print]

PMID:
27078619
2.

T-cell activation independently associates with immune senescence in long-term antiretroviral drug-treated HIV-1-infected individuals.

Cobos Jiménez V, Wit FW, Joerink M, Maurer I, Harskamp AM, Schouten J, Prins M, van Leeuwen EM, Booiman T, Deeks SG, Reiss P, Kootstra NA; AGEhIV Study Group.

J Infect Dis. 2016 Apr 12. pii: jiw146. [Epub ahead of print]

PMID:
27073222
3.

Identifying key drivers of the impact of an HIV cure intervention in sub-Saharan Africa.

Phillips A, Cambiano V, Revill P, Nakagawa F, Lundgren J, Bansi-Matharu L, Mabugu T, Sculpher M, Garnett G, Staprans S, Becker S, Murungu J, Lewin SR, Deeks SG, Hallett T.

J Infect Dis. 2016 Mar 30. pii: jiw120. [Epub ahead of print]

PMID:
27034345
4.

Immune Activation and HIV-Specific CD8+ T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers.

Ganesh A, Lemongello D, Lee E, Peterson J, McLaughlin BE, Ferre AL, Gillespie GM, Fuchs D, Deeks SG, Hunt PW, Price RW, Spudich SS, Shacklett BL.

AIDS Res Hum Retroviruses. 2016 May 2. [Epub ahead of print]

PMID:
27019338
5.

Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial.

Serrano-Villar S, Sainz T, Ma ZM, Utay NS, Chun TW, Mann S, Kashuba AD, Siewe B, Albanese A, Troia-Cancio P, Sinclair E, Somasunderam A, Yotter T, Deeks SG, Landay A, Pollard RB, Miller CJ, Moreno S, Asmuth DM.

PLoS Pathog. 2016 Mar 25;12(3):e1005540. doi: 10.1371/journal.ppat.1005540. eCollection 2016 Mar.

6.

Do Biomarkers Of Inflammation, Monocyte Activation And Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People?

So-Armah KA, Tate JP, Chang CH, Butt AA, Gerschenson M, Gibert CL, Leaf D, Rimland D, Rodriguez-Barradas MC, Budoff MJ, Samet JH, Kuller LH, Deeks SG, Crothers KA, Tracy RP, Crane HM, Sajadi MM, Tindle HA, Justice AC, Freiberg MS; The VACS Project Team.

J Acquir Immune Defic Syndr. 2016 Feb 13. [Epub ahead of print]

PMID:
26885807
7.

Immunologic profiles distinguish aviremic HIV-infected adults.

Ramirez CM, Sinclair E, Epling L, Lee SA, Jain V, Hsue PY, Hatano H, Conn D, Hecht FM, Martin JN, Mccune JM, Deeks SG, Hunt PW.

AIDS. 2016 Feb 5. [Epub ahead of print]

PMID:
26854811
8.

Persistence of integrated HIV DNA in CXCR3 + CCR6 + memory CD4+ T-cells in HIV-infected individuals on antiretroviral therapy.

Khoury G, Anderson JL, Fromentin R, Hartogensis W, Smith MZ, Bacchetti P, Hecht FM, Chomont N, Cameron PU, Deeks SG, Lewin SR.

AIDS. 2016 Jan 23. [Epub ahead of print]

PMID:
26807971
9.

Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial.

Serrano-Villar S, Sainz T, Ma ZM, Utay NS, Wook-Chun T, Mann S, Kashuba AD, Siewe B, Albanese A, Troia-Cancio P, Sinclair E, Somasunderam A, Yotter T, Deeks SG, Landay A, Pollard RB, Miller CJ, Moreno S, Asmuth DM.

PLoS Pathog. 2016 Jan 21;12(1):e1005381. doi: 10.1371/journal.ppat.1005381. eCollection 2016 Jan. Erratum in: PLoS Pathog. 2016 Mar;12(3):e1005540.

10.

Post-Treatment Controllers: Role in HIV "Cure" Research.

Cockerham LR, Hatano H, Deeks SG.

Curr HIV/AIDS Rep. 2016 Feb;13(1):1-9. doi: 10.1007/s11904-016-0296-x.

PMID:
26781112
11.

Endothelin-1 Predicts Hemodynamically Assessed Pulmonary Arterial Hypertension in HIV Infection.

Parikh RV, Ma Y, Scherzer R, Heringer AS, Macgregor JS, Martin JN, Deeks SG, Ganz P, Hsue PY.

PLoS One. 2016 Jan 11;11(1):e0146355. doi: 10.1371/journal.pone.0146355. eCollection 2016.

12.

TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection.

Chew GM, Fujita T, Webb GM, Burwitz BJ, Wu HL, Reed JS, Hammond KB, Clayton KL, Ishii N, Abdel-Mohsen M, Liegler T, Mitchell BI, Hecht FM, Ostrowski M, Shikuma CM, Hansen SG, Maurer M, Korman AJ, Deeks SG, Sacha JB, Ndhlovu LC.

PLoS Pathog. 2016 Jan 7;12(1):e1005349. doi: 10.1371/journal.ppat.1005349. eCollection 2016 Jan.

13.

Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy.

Cain LE, Saag MS, Petersen M, May MT, Ingle SM, Logan R, Robins JM, Abgrall S, Shepherd BE, Deeks SG, Gill MJ, Touloumi G, Vourli G, Dabis F, Vandenhende MA, Reiss P, van Sighem A, Samji H, Hogg RS, Rybniker J, Sabin CA, Jose S, Del Amo J, Moreno S, Rodríguez B, Cozzi-Lepri A, Boswell SL, Stephan C, Pérez-Hoyos S, Jarrin I, Guest JL, Monforte AD, Antinori A, Moore R, Campbell CN, Casabona J, Meyer L, Seng R, Phillips AN, Bucher HC, Egger M, Mugavero MJ, Haubrich R, Geng EH, Olson A, Eron JJ, Napravnik S, Kitahata MM, Van Rompaey SE, Teira R, Justice AC, Tate JP, Costagliola D, Sterne JA, Hernán MA; Antiretroviral Therapy Cohort Collaboration, the Centers for AIDS Research Network of Integrated Clinical Systems, and the HIV-CAUSAL Collaboration.

Int J Epidemiol. 2015 Dec 31. pii: dyv295. [Epub ahead of print]

PMID:
26721599
14.

HIV reservoirs: what, where and how to target them.

Churchill MJ, Deeks SG, Margolis DM, Siliciano RF, Swanstrom R.

Nat Rev Microbiol. 2016 Jan;14(1):55-60. doi: 10.1038/nrmicro.2015.5. Epub 2015 Nov 30.

PMID:
26616417
15.

Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study.

Elliott JH, McMahon JH, Chang CC, Lee SA, Hartogensis W, Bumpus N, Savic R, Roney J, Hoh R, Solomon A, Piatak M, Gorelick RJ, Lifson J, Bacchetti P, Deeks SG, Lewin SR.

Lancet HIV. 2015 Dec;2(12):e520-9. doi: 10.1016/S2352-3018(15)00226-X. Epub 2015 Nov 17.

PMID:
26614966
16.

Lack of Evidence for Molecular Mimicry in HIV-Infected Subjects.

Burbelo PD, Klimavicz JS, Deeks SG, Kovacs JA, Ragheb JA.

PLoS One. 2015 Nov 23;10(11):e0127662. doi: 10.1371/journal.pone.0127662. eCollection 2015.

17.

Virome analysis of antiretroviral-treated HIV patients shows no correlation between T-cell activation and anelloviruses levels.

Li L, Deng X, Da Costa AC, Bruhn R, Deeks SG, Delwart E.

J Clin Virol. 2015 Nov;72:106-13. doi: 10.1016/j.jcv.2015.09.004. Epub 2015 Oct 8.

PMID:
26479202
18.

A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals.

Procopio FA, Fromentin R, Kulpa DA, Brehm JH, Bebin AG, Strain MC, Richman DD, O'Doherty U, Palmer S, Hecht FM, Hoh R, Barnard RJ, Miller MD, Hazuda DJ, Deeks SG, Sékaly RP, Chomont N.

EBioMedicine. 2015 Jun 27;2(8):872-81. doi: 10.1016/j.ebiom.2015.06.019. eCollection 2015 Aug.

19.

Effect of therapeutic intensification followed by HIV DNA prime and rAd5 boost vaccination on HIV-specific immunity and HIV reservoir (EraMune 02): a multicentre randomised clinical trial.

Achenbach CJ, Assoumou L, Deeks SG, Wilkin TJ, Berzins B, Casazza JP, Lambert-Niclot S, Koup RA, Costagliola D, Calvez V, Katlama C, Autran B, Murphy RL; EraMune 02 study team.

Lancet HIV. 2015 Mar;2(3):e82-91. doi: 10.1016/S2352-3018(15)00026-0. Epub 2015 Feb 17.

PMID:
26424549
20.

CD4/CD8 ratio: an emerging biomarker for HIV.

Serrano-Villar S, Deeks SG.

Lancet HIV. 2015 Mar;2(3):e76-7. doi: 10.1016/S2352-3018(15)00018-1. Epub 2015 Feb 6. No abstract available.

PMID:
26424546
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk